The Office of Justice Programs Bureau of Justice Assistance (BJA) today announced funding of more than $8.8 million in 20 separate awards to 19 state health and pharmacy boards and departments to better track and share prescription drug information to help reduce drug abuse, misuse, and diversion.NoneMisuse of prescription drugs is a national problem, that requires the cooperative efforts of all medical, health, pharmaceutical, law enforcement agencies, and other partners to solve, said Assistant Attorney General Karol V. Mason of the Office of Justice Programs. These awards provide a foundation of resources for enabling data collection, sharing, and collaboration to help prevent prescription medication misuse and abuse.These awards support collaboration between law enforcement, prosecutors, public health, treatment professionals, pharmacies, and the medical community to promote strategies that inform effective policies, support investigations, and offer treatment intervention and prevention efforts for at-risk individuals and communities. The awards are administered by BJA in coordination with a myriad of partners, including the U.S. Drug Enforcement Administrations Office of Diversion Control, the Office of National Drug Control Policy, the U.S. Centers for Disease Control and Prevention, the U.S. Food and Drug Administration, and the Substance Abuse and Mental Health Service Administration.Todays awardees include:Todays awards were announced as part of Prescription Opioid and Heroin Epidemic Awareness Week, which President Obama established by proclamation Sept. 16. Departments across the federal government are continuing to use all available tools to combat this epidemic by expanding evidence-based prevention and treatment programs, increasing access to the overdose-reversal medicine naloxone, improving opioid prescribing practices, and supporting targeted enforcement activities.None